Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes

Diabetes

Volumn 46, Issue 8, 1997, Pages 1270-1275

  Hawa, Mohammed ^a   Rowe, Rachael ^a   Lan, Michael S ^b   Notkins, Abner L ^b   Pozzilli, Paolo ^c   Christie, Michael R ^d   Leslie, R David G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; TWIN DISCORDANCE;

EID: 0030803535     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.8.1270     Document Type: Article

References (31)

1. Leslie RDG, Gale EAM: Aetiology of insulin dependent diabetes. In Diabetes: Clinical Science in Practise. Leslie RDG, Robbins DC, Eds. Cambridge, Cambridge Univ. Press, 1995, p. 134-156
2. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetes before insulin treatment. Science 222:1337-1339, 1983
3. Baekkeskov S, Aanstoot HJ, Christgau S, Christgau S, Retz A, Solimena M, Cascalho M, Folli F, Richter-Ohlsen H, De Camilli P: Identification of the 64K autoantigen an insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
4. Christie MR, Tun RYM, Lo SSS, Cassidy D, Brown TJ, Hollands J, Shattock M, Bottazzo GF, Leslie RDG: Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM Diabetes 41:782-787, 1992
5. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41:183-186, 1992
6. Bingley PJ, Christie MR, Bonfanti R, Bonifacio E, Shattock M, McNally JM, Gale EAM, Bottazzo GF: Combined analysis of autoantibodies enhances prediction of IDDM in islet cell antibody (ICA) positive relatives. Diabetes 43:1304-1310, 1994
7. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
8. Lan MS, Wasserfell C, MacLaren NK, Notkins AL: IA-2, a transmembrane protein of the protein tyrosine phosphatase, is a major autoantigen in insulindependent diabetes mellitus. Proc Natl Acad Sci USA 93:6367-6370, 1996
9. Jia Lu, Qing Li, Hong Xie, Zhi-Jian Chen, Borovitskaya AE, Maclaren NK, Notions AL, Lan MS: Identification of a second transmembrane protein tyrosine phosphatase, IA-2β, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment Proc Natl Acad Sci USA 93:2307-2311, 1996
10. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000 and 40,000 Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511, 1995
11. Lan MS, Lu J, Goto Y, Notions AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma DNA Cell Biol 13:505-514, 1994
12. Lu J, Notkins AL, Lan MS: Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family. Biochem Biophys Res Commun 204:930-936, 1994
13. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories with glucose intolerance. Diabetes 28:1039-1057, 1979
14. Olmos P, A'Hern R, Heaton DA, Millward BA, Risley D, Pyke DA, Leslie RDG: The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31:747-750, 1988
15. Tun RYM, Peakman M, Alviggi L, Hussain MJ, Lo SSS, Shattock M, Pyke DA, Bottazzo GF, Vergani D, Leslie RDG: The importance of persistent cellular and humoral immune changes in the prediabetic period: a prospective identical twin study. BMJ 308:1063-1068, 1994
16. Schmidli RS, Colman PG, Bonifacio E, and Participating Laboratories: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 44:636-640, 1995
17. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tbomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385, 1994
18. Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Bonifacio E: Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 39:1223-1226, 1996
19. Morales J, Puig-Domingo M, Mauricio D, Piquer S, Vinets I, Lampasona V, Bonifacio E, de Leiva A: IA2 and GAD 65 antibodies complement islet cell antibodies in IDDM prediction (Abstract). Diabetologia 39 (Suppl. 1):327, 1996
20. 65 autoantibodies in new onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99, 1997
21. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E: Autoantibodies in insulin-dependent diabetes recognise distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157:2707-2711, 1996
22. Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Hetropaolo M, Eisenbarth GS: ICA512 autoantibody radioassay. Diabetes 44:1340-1344, 1995
23. Leslie RDG, Elliott RB: Early environmental events as a cause of IDDM: evidence and implications. Diabetes 43:843-850, 1994
24. Verge CF, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson RS, Soeldner JS, Eisenbarth GS: Late progression to diabetes and evidence for chronic cell autoimmunity in identical twins of patients with type 1 diabetes. Diabetes 44:1176-1179, 1995
25. Bingiey P, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, Scott RDM, Bottazzo GF, Gale EAM: Can islet cell antibodies predict IDDM in the general population? Diabetes Care 16:45-50, 1993
26. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
27. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA, the DENIS Study Group: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetohgia 39:1351-1356, 1996
28. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingiey PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
29. Hawkes CJ, Wasmeier C, Christie MR, Hutton CJ: Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 45:1187-1192, 1996
30. 65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 97:2772-2783, 1996
31. Kaufman DL, Care-Salzier M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993